Corpus Intelligence IC Memo — MELBOURNE REGIONAL MEDICAL CENTER 2026-04-26 06:37 UTC
IC Memo — MELBOURNE REGIONAL MEDICAL CENTER
Investment Committee Memorandum | FL | 96 beds | Grade C | EBITDA uplift $8.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MELBOURNE REGIONAL MEDICAL CENTER

CCN 100291 | BREVARD, FL | 96 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MELBOURNE REGIONAL MEDICAL CENTER is a 96-bed suburban community hospital in BREVARD, FL with $120.2M in net patient revenue and a 7.3% operating margin. The hospital serves a payer mix of 26.0% Medicare, 7.7% Medicaid, and 66.4% commercial.

Thesis: Turnaround. Our ML models identify $8.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.3% to 14.7% (+736bps).

Net Revenue HCRIS$120.2M
Current EBITDA COMPUTED$8.8M
Operating Margin COMPUTED7.3%
Occupancy HCRIS51.2%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS10.9%
Distress Probability ML46.5%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
118
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 7.3% places it above the state median. Among 118 size-comparable peers (48-192 beds), the median margin is 3.7%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (48-192), prioritizing same-state peers. 118 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MELBOURNE REGIONAL MEDICAL CEN (Target)FL96$120.2M7.3%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH WESLEY CHAPELFL169$360.1M17.0%
ORLANDO HEALTH SOUTH LAKE HOSPFL167$331.8M7.2%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
HOMESTEAD HOSPITALFL159$270.4M-11.1%
NEMOURS CHILDRENS HOSPITALFL130$268.7M-10.2%
MEMORIAL HOSPITAL MIRAMARFL178$267.4M14.0%
DOCTORS HOSPITALFL130$250.0M0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $8.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.5M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$77K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.5M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$77K
Total EBITDA Uplift$8.8M
Current EBITDA$8.8M
+ RCM Uplift+$8.8M
Pro Forma EBITDA$17.6M
Current Margin7.3%
Pro Forma Margin14.7%
WC Released (1x)$4.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$13.5M$146.4M10.83x61.0%
Base (11x exit)10.0x11.0x$13.5M$165.5M12.24x65.0%
Bull Case9.0x11.0x$12.2M$199.1M16.36x74.9%
Bull (12x exit)9.0x12.0x$12.2M$220.8M18.14x78.5%
Bear Case11.0x10.0x$14.9M$97.8M6.58x45.8%
Bear (11x exit)11.0x11.0x$14.9M$112.4M7.56x49.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 118 hospitals with 48-192 beds
  • Same-state prioritization (n=119)
  • Comp margins: P25=-8.4% / P50=3.7% / P75=13.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.